semaglutide oral fda approval Approves Semaglutide: First GLP-1 Weight Loss Pill Novo says it's submitted obesity

From R&D to commercial manufacturing, we offer full-lifecycle solutions

Putting This Into Practice Track your blood glucose patterns for 2 weeks before starting either medication to establish baseline control and identify problem times Plan dose escalations around your schedule, avoiding important events or travel within 3-4 days of dose increases when side effects peak Establish a consistent injection day and set weekly reminders, choosing a day when youre typically home and relaxed Modify meal composition during initial treatment by reducing portion sizes and fat content to minimise nausea Monitor weight weekly at the same time of day to track treatment response and adjust expectations appropriately When to Seek Professional Help Severe abdominal pain that radiates to the back Persistent vomiting preventing fluid intake for more than 24 hours Signs of allergic reaction, including rash, itching, or swelling Visual changes or severe headaches Symptoms of gallbladder problems, including right upper quadrant pain after meals Blood glucose readings consistently below 4.0 mmol/L Inability to tolerate starting doses despite proper administration technique Commonly Asked Questions Can I switch between tirzepatide and semaglutide if one isnt working

Eating earlier, curbing late cravings, and reducing reflux help you fall asleep faster and wake less

In August 2025, accelerated approval was granted for treating noncirrhotic MASH with F2F3 fibrosis, contingent on confirmatory ESSENCE outcomes

In contrast, a significant decrease in systolic blood pressure occurred at T6 compared with T0 ( Table 3 )